Cerena Chen
Stock Analyst at Wells Fargo
(2.91)
# 1,715
Out of 5,012 analysts
6
Total ratings
80%
Success rate
23.42%
Average return
Main Sectors:
Stocks Rated by Cerena Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MSTR Strategy | Downgrades: Equal-Weight | $65 → $54 | $330.80 | -83.68% | 1 | Sep 30, 2025 | |
| MTSR Metsera | Initiates: Overweight | $65 | $52.84 | +23.01% | 1 | Jun 20, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Overweight | $40 → $35 | $25.98 | +34.72% | 1 | May 8, 2025 | |
| AXSM Axsome Therapeutics | Maintains: Overweight | $160 → $165 | $118.71 | +38.99% | 3 | May 6, 2025 |
Strategy
Sep 30, 2025
Downgrades: Equal-Weight
Price Target: $65 → $54
Current: $330.80
Upside: -83.68%
Metsera
Jun 20, 2025
Initiates: Overweight
Price Target: $65
Current: $52.84
Upside: +23.01%
Amphastar Pharmaceuticals
May 8, 2025
Maintains: Overweight
Price Target: $40 → $35
Current: $25.98
Upside: +34.72%
Axsome Therapeutics
May 6, 2025
Maintains: Overweight
Price Target: $160 → $165
Current: $118.71
Upside: +38.99%